Tracked deals
3
3 tracked deals across 2024-2025.
Operating Company
Software
MediSpend
Portsmouth, New Hampshire, United States
Formerly known as RLDatix Life Sciences
MediSpend is a global provider of cloud-based compliance software-as-a-service and related services that help life sciences organizations grow their business compliantly, reducing compliance risk and improving customer engagements.
- Focus Areas
- Life sciences compliance SaaS, Commercial compliance, GRC (governance, risk and compliance)
- Website
- medispend.com
Recent pace
0
0 tracked deals announced in the last 12 months.
Deal mix
Addon
2 addon · 1 buyout
MediSpend Acquisition Volume by Year
Last 2 years
Supporting Data
Recent Transactions
-
August 4, 2025
- Buyer
- MediSpend
- Target
- Alucio
- Industry
- Cloud & SaaS
- Location
- California, United States
- Type
- Addon
MediSpend, a provider of compliance and stakeholder engagement solutions for the life sciences industry, has acquired Alucio, the maker of the AI-enabled BEACON content management and HCP engagement platform. The acquisition adds AI-driven content management and personalized scientific-exchange capabilities to MediSpend's platform, expanding its offerings for medical affairs, clinical affairs and market access teams.
-
January 27, 2025
- Buyer
- MediSpend
- Target
- Real Life Sciences
- Industry
- Cloud & SaaS
- Location
- Pennsylvania, United States
- Type
- Buyout
MediSpend, a Susquehanna Growth Equity‑backed life sciences technology company, has acquired Real Life Sciences (RLS), a provider of advanced anonymization and redaction solutions for clinical trial data. The deal expands MediSpend's Governance, Risk and Compliance (GRC) capabilities—adding RLS Protect SaaS and expert anonymization services to support pharma, biotech and CRO clients with regulatory disclosure and participant privacy.
-
May 22, 2024
- Buyer
- MediSpend
- Target
- MedCompli
- Industry
- Software
- Location
- Florida, United States
- Type
- Addon
MediSpend, a Portsmouth, New Hampshire–based commercial compliance technology company, has acquired MedCompli, a life-sciences compliance software and services provider, effective May 17, 2024. The acquisition expands MediSpend’s product portfolio and subject-matter expertise—bringing complementary SaaS and advisory capabilities into its PE-backed platform to better serve life sciences customers globally.
Related Acquisition Pages
Selling a company? Get in front of buyers like MediSpend
Turn tracked acquisition activity into an outreach-ready buyer list.